Suppr超能文献

他汀类药物在腹主动脉瘤腔内修复术中保护肾功能的证据。

Evidence that statins protect renal function during endovascular repair of AAAs.

机构信息

Department of Vascular Surgery, University Hospital, University of Cologne, Cologne, Germany.

出版信息

Eur J Vasc Endovasc Surg. 2010 Nov;40(5):608-15. doi: 10.1016/j.ejvs.2010.05.006. Epub 2010 Jun 14.

Abstract

OBJECTIVES

Several studies have documented a slight but significant deterioration of renal function after endovascular repair of abdominal aortic aneurysm (AAA) (EVAR). The aim of this retrospective study was therefore to investigate whether medication with statins may favourably affect perioperative renal function.

MATERIAL AND METHODS

From January 2000 to January 2008, out of a total cohort of 287 elective patients receiving endovascular repair of their AAA or aortoiliac aneurysm, 127 patients were included in the present study, as their medication was reliably retrievable. Patients were divided according to whether their medication included statins (>3 months). Second, they were subdivided according to their supra- (SR) or infrarenal (IR) endograft fixation. Serum creatinine (SCr) and creatinine (CrCl) clearance were determined preoperatively, postoperatively, at 6 and 12 months. Patients with known pre-existing renal disease, with incorrect placement of the stent graft resulting in severe renal artery stenosis, and with occlusion or renal parenchymal infarction were excluded from the study.

RESULTS

Patients receiving an infrarenal fixation of their graft had no change in the renal function, regardless whether they were on statins or not. In patients with SR fixation not receiving statins, a deterioration in renal function was observed in the early postoperative period ((SCr) preoperative vs. SCr postoperative: 1.02±0.2 vs. 1.11±0.28, p<0.001 and (Cr.Cl) preoperative vs. Cr.Cl postoperative: 74.1±21.4 vs. 68.0±21.4, p<0.001), whereas patients on statins experienced no change in renal function (SCr preoperative vs. SCr postoperative: 0.99±0.24 vs. 1.02±0.20n.s. and Cr.Cl preop vs. Cr.Clpostop.: 76.4±19.1 vs. 74.28±20.50, n.s.). During follow-up, a constant worsening of renal function at 6 and 12 months was observed, irrespective of the medication with statins.

CONCLUSIONS

The present study suggests a slight immediate deterioration of the renal function using (SR) fixation, and this could be prevented by the use of statins. During follow-up, statins did not protect from further renal deterioration. Broader studies are needed to confirm a definitive relation between statin use and renal protection during the endovascular repair of AAA.

摘要

目的

多项研究记录表明,腹主动脉瘤(AAA)血管内修复(EVAR)后肾功能会出现轻微但显著的恶化。本回顾性研究的目的是调查他汀类药物治疗是否会对围手术期肾功能产生有利影响。

材料和方法

2000 年 1 月至 2008 年 1 月,在 287 例接受腹主动脉瘤或主动脉-髂动脉瘤血管内修复的择期患者中,共有 127 例患者被纳入本研究,因为他们的药物治疗是可靠的。根据药物治疗中是否包括他汀类药物(>3 个月)将患者分为两组。其次,根据其支架移植物的肾上(SR)或肾下(IR)固定情况进一步细分。在术前、术后、术后 6 个月和 12 个月时测定血清肌酐(SCr)和肌酐清除率(CrCl)。排除已知存在肾脏疾病、支架移植物位置不当导致严重肾动脉狭窄以及存在闭塞或肾实质梗死的患者。

结果

接受肾下固定的患者,无论是否服用他汀类药物,肾功能均无变化。在未服用他汀类药物的 SR 固定患者中,术后早期肾功能恶化((SCr)术前与术后:1.02±0.2 与 1.11±0.28,p<0.001 和(Cr.Cl)术前与术后:74.1±21.4 与 68.0±21.4,p<0.001),而服用他汀类药物的患者肾功能无变化(SCr 术前与术后:0.99±0.24 与 1.02±0.20n.s. 和 Cr.Cl 术前与术后:76.4±19.1 与 74.28±20.50,n.s.)。在随访期间,无论是否服用他汀类药物,6 个月和 12 个月时肾功能均持续恶化。

结论

本研究提示 SR 固定后肾功能有轻微的即刻恶化,而使用他汀类药物可预防这种恶化。在随访期间,他汀类药物并不能防止肾功能进一步恶化。需要进一步的广泛研究来确认他汀类药物在 EVAR 治疗 AAA 期间与肾脏保护之间的明确关系。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验